Anidulafungin-Induced Alopecia: A Case Report

    March 2014 in “ Annals of Pharmacotherapy ”
    Jesus Ruiz‐Ramos, Miguel Salavert-Lletí, Emilio Monte-Boquet … José Luis Poveda‐Andrés
    Studysummary This case report suggests that anidulafungin may be associated with hair loss, highlighting the need for physicians to monitor this potential adverse effect.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on journals.sagepub.com →
    Discuss this study in the Community →

    Research cited in this study 6

    1. Drugs and Hair Loss: Mechanisms and Clinical Implications Dermatologic Clinics · 2012
    2. Hair Loss in Women The New England Journal of Medicine · 2007
    3. Drug Reactions Affecting Hair: Diagnosis Dermatologic Clinics · 2007
    4. Telogen Effluvium Caused by Magnesium Valproate and Lamotrigine Acta dermato-venereologica · 2004
    5. Burden of Hair Loss: Stress and the Underestimated Psychosocial Impact of Telogen Effluvium and Androgenetic Alopecia Journal of Investigative Dermatology · 2004
    6. Drug-Induced Hair Loss and Hair Growth Drug Safety · 1994

    Related research 1

    1. Anidulafungin-Induced Alopecia: A Case Report Annals of Pharmacotherapy · 2014